Wei L - Search Results

1

Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.

Wei L, Han T, Yang D, Heo J, Shang J, Cheng J, Chen X, Xie Q, Kim JH, Kalmeijer R, Ouwerkerk-Mahadevan S, Hoeben E, Lenz O, Verbinnen T, Sinha R, Li M, Scott J, Peeters M, Witek J; TIGER team. Wei L, et al. J Gastroenterol Hepatol. 2016 May;31(5):912-20. doi: 10.1111/jgh.13288. J Gastroenterol Hepatol. 2016. PMID: 26777137 Clinical Trial.

2

Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area.

Fan CL, Wei L, Jiang D, Chen HS, Gao Y, Li RB, Wang Y. Fan CL, et al. Among authors: wei l. World J Gastroenterol. 2003 Sep;9(9):2012-6. doi: 10.3748/wjg.v9.i9.2012. World J Gastroenterol. 2003. PMID: 12970896 Free PMC article.

3

Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up.

Fan W, Zhu W, Wei L, Wang Q, Yin L, Du S, Zhuang H. Fan W, et al. Among authors: wei l. J Gastroenterol. 2005 Jan;40(1):43-51. doi: 10.1007/s00535-004-1446-2. J Gastroenterol. 2005. PMID: 15692788

4

[Screening of target autoantigen in hepatocytes from hepatocyte cDNA library by phage display technique].

Li YR, Zhang LY, Cheng J, Wang PZ, Xie W, Wei L. Li YR, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):857-8. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 17125622 Chinese. No abstract available.

5

[Analysis and state of HCV genotype 6a infection].

Zhang R, Li JQ, Liu LJ, Du SC, Wei L. Zhang R, et al. Among authors: wei l. Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Dec 18;38(6):614-7. Beijing Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 17173082 Free article. Chinese.

6

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Zhao H, et al. Among authors: wei l. Clin Infect Dis. 2007 Feb 15;44(4):541-8. doi: 10.1086/511042. Epub 2007 Jan 11. Clin Infect Dis. 2007. PMID: 17243057 Clinical Trial.

7

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.

Zhang Q, Wang Y, Wei L, Jiang D, Wang JH, Rao HY, Zhu L, Chen H, Fei R, Cong X. Zhang Q, et al. Among authors: wei l. J Gastroenterol Hepatol. 2008 Nov;23(11):1747-61. doi: 10.1111/j.1440-1746.2007.04985.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2008. PMID: 17559358

8

Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.

Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R. Jia Y, et al. Among authors: wei l. J Gastroenterol Hepatol. 2007 Aug;22(8):1278-85. doi: 10.1111/j.1440-1746.2007.04957.x. Epub 2007 Jun 12. J Gastroenterol Hepatol. 2007. PMID: 17565587

9

Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.

Ma H, Wei L, Guo F, Zhu S, Sun Y, Wang H. Ma H, et al. Among authors: wei l. J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1250-8. doi: 10.1111/j.1440-1746.2008.05499.x. Epub 2008 Jul 8. J Gastroenterol Hepatol. 2008. PMID: 18624896

10

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.

Peng D, Han Y, Ding H, Wei L. Peng D, et al. Among authors: wei l. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1082-8. doi: 10.1111/j.1440-1746.2008.05478.x. J Gastroenterol Hepatol. 2008. PMID: 18707599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,234 results

Search Page

Filters